Gastroduodenal effects of nonsteroidal antiinflammatory drugs

References

• Baum C, Kennedy DL, Forbes MB. Utilization or nonsteroidal anti inflammatory drugs. Arthritis Rheum 1985: 28(6): 686–92
   PubMed Web of Science ®Google Scholar
• Ballet AJ. Nonsteroidal anti-inflammatory drugs. In: Kelley WN. ed. Textbook of rheumatology. 3d ed. Philadelphia: WB Saunders. 1985: 752–73
   Google Scholar
• Coles LS, Fries JF, Kraines RG, et al. From experiment to experience: side effects of nonsteroidal anti-Inflammatory drugs. Am J Med 1983: 74(5): 820–8
   PubMed Web of Science ®Google Scholar
• Larkai EN, Smith JL, Lidsky MD, et al. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol 1987: 82(11): 1153–8
   PubMed Web of Science ®Google Scholar
• Collins AJ, Da vies J, Dixon SA. Contrasting presentation and findings between patients with rheumatic complaints taking nonsteroidal anti-inflammatory drugs and a general population referred for endoscopy. Br J Rheumatol 1986: 25(1): 50–3
   PubMedGoogle Scholar
• Bijlsma JW. Treatment of endoscopy-negative NSAID-induced upper gastrointestinal symptoms with cimetidine: an international multicentre collaborative study. Aliment Pharmacol Ther 1988: 2(Suppl 2): 75–84
   PubMedGoogle Scholar
• Bijlsma JW. Treatment of NSAID-induced upper gastrointestinal lesions with cimetidine: an international multicentre collaborative study. Aliment Pharmacol Ther 1988: 2(Suppl 2): 85–96
   PubMedGoogle Scholar
• Caldwell JR. Roth SH, Wu WC, et al. Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage. Am J Med 1987: 83(Suppl 3B): 74–82
   PubMed Web of Science ®Google Scholar
• Wu WC, Semble EL, Castell DC, et al. Sucralfate therapy of nonsteroidal anti-inflammatory drug gastritis. (Abstr) Gastroenterology 1985: 88(5 Pt 2): 1636
   Web of Science ®Google Scholar
• Graham DY, Smith JL, Dobbs SM. Gastric adaptation occurs with aspirin administration in man. Dig Dis Sci 1983: 28(1): 1–6
   PubMed Web of Science ®Google Scholar
• Silvoso GR, Ivey KJ, Butt JH, et al. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 1979: 91(4): 517–20
   PubMed Web of Science ®Google Scholar
• Kimmey MB, Silverstein FE, Saunders DR, et al. Time course of aspirin-induced gastroduodenal mucosal injury and gastrointestinal symptoms. (Abstr) Gastroenterology 1987: 92: 1466
   Web of Science ®Google Scholar
• Graham DY, Smith JL, Spjut HJ. et al. Gastric adaptation: studies in humans during continuous aspirin administration. Gastroenterology 1988: 95(2): 327–33
   PubMed Web of Science ®Google Scholar
• Lanza FL. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. Am J Med 1984: 77(1 A): 19–24
   PubMedGoogle Scholar
• Kimmey MB, Silverstein FE, Saunders DR, et al. Reduction of endoscopically assessed acute aspirin-induced gastric mucosal injury with cimetidine. Dig Dis Sci 1987: 32(8): 851–6
   PubMed Web of Science ®Google Scholar
• Berkowitz JM, Rogenes PR, Sharp JT, et al. Ranitidine protects against gastroduodenal mucosal damage associated with chronic aspirin therapy. Arch Intern Med 1987: 147(12): 2137–9
   PubMedGoogle Scholar
• Lanza FL, Aspinall RL, Swabb EA, et al. Double-blind. placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology 1988: 95(2): 289–94
   PubMed Web of Science ®Google Scholar
• Lanza F, Peace K, Gustitus L, et al. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration. Am J Gastroenterol 1988: 83(2): 143–6
   PubMed Web of Science ®Google Scholar
• Roth SH, Bennett RE. Nonsteroidal anti-inflammatory drug gastropathy: recognition and response. Arch Intern Med 1987: 147(12): 2093–100
   PubMedGoogle Scholar
• Carson JL, Strom BL, Soper KA. et al. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med 1987: 147(1): 85–8
   PubMedGoogle Scholar
• Graham DY, Smith JL. Aspirin and the stomach. Ann Intern Med 1986: 104(3): 390–8
   PubMed Web of Science ®Google Scholar
• Pye G, Ballantyne KC, Armitage NC, et al. Influence of nonsteroidal anti-inflammatory drugs on the outcome of faecal occult blood tests in screening for colorectal cancer. Br Med J (Clin Res) 1987: 294: 1510–1
   PubMedGoogle Scholar
• Manniche C, Malchow-Moller A, Andersen JR. et al. Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease. Gut 1987: 28(2): 226–9
   PubMedGoogle Scholar
• Farah D, Sturrock RD, Russell RI. Peptic ulcer in rheumatoid arthritis. Ann Rheum Dis 1988: 47(6): 478–80
   PubMed Web of Science ®Google Scholar
• O'Laughlin JC, Silvoso GK, Ivey KJ. Resistance to medical therapy of gastric ulcers in rheumatic disease patients taking aspirin: a double-blind study with cimetidine and follow-up. Dig Dis Sci 1982: 27(11): 976–80
   PubMed Web of Science ®Google Scholar
• Agrawal NM, Roth S, Mahowald M, et al. Protection and healing of gastro-duodenal mucosal damage by misoprostol in rheumatoid arthritis patients under continuing aspirin therapy. (Abstr) Am J Gastroenterol 1987: 82: 159
   PubMedGoogle Scholar
• Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 1987: 28(5): 527–32
   PubMed Web of Science ®Google Scholar
• Somerville K, Faulkner G, Langman M. Nonsteroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986: 1(8479): 462–4
   PubMed Web of Science ®Google Scholar
• Bartle WR, Gupta AK, Lazor J. Nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding: a case- control study. Arch Intern Med 1986: 146(12): 2365–7
   PubMedGoogle Scholar
• Guess HA, West R, Strand LM, et al. Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan. Canada 1983. J Clin Epidemiol 1988: 41(1): 35–45
   PubMed Web of Science ®Google Scholar
• Jick H. Effects of aspirin and acetaminophen in gastrointestinal hemorrhage: results from the Boston Collaborative Drug Surveillance Program. Arch Intern Med 1981: 141(3 Spec No.): 316–21
   PubMedGoogle Scholar
• Griffin MR, Ray WA, Schaffner W. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988: 109(5): 359–63
   PubMed Web of Science ®Google Scholar
• Ehsanullah RS. Page MC, Tildesley G, et al. Prevention of gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs: controlled trial of ranitidine. Br Med J 1988: 297(6655): 1017–21
   PubMed Web of Science ®Google Scholar
• Lanza F, Robinson M, Bowers J, et al. A multicenter double-blind comparison of ranitidine vs. placebo in the prophylaxis of nonsteroidal anti inflammatory drug (NSAID) induced lesions in gastric and duodenal mucosae. (Abstr) Gastroenterology 1988: 94(5): A250
   Google Scholar
• Graham DY, Agrawal NM, Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet 1988: 2(8623): 1277–80
   PubMed Web of Science ®Google Scholar